Infliximab dose adjustment can improve the clinical and radiographic outcomes of rheumatoid arthritis patients: REVIVE study results

Infliximab dose adjustment can improve the clinical and radiographic outcomes of rheumatoid arthritis patients: REVIVE study results

Yuji Nozaki, Yasuaki Nagare, Chisato Ashida, Daisuke Tomita, Akinori Okada, Asuka Inoue, Koji Kinoshita, Masanori Funauchi, Itaru Matsumura Department of Hematology and Rheumatology, Kindai University School of Medicine, Osaka, Japan Purpose: We evaluated the clinical responses and radiographic outc...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Nozaki Y, Nagare Y, Ashida C, Tomita D, Okada A, Inoue A, Kinoshita K, Funauchi M, Matsumura I
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2018
Materias:
rheumatoid arthritis
DAS28
infliximab
mTSS
dose adjustment
REVIVE
Medicine (General)
R5-920
Acceso en línea:https://doaj.org/article/a781296252d949fda2d27a927e033222
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Ejemplares similares